Ashwini Patil - Publications

A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 04, 2025

Creating an engine of scientific discovery, an Indo-Japan perspective: learnings from IJNTC 2025 workshop.

Journal: NPJ systems biology and applications

Published: August 16, 2025

Whole-body molecular and cellular mapping of the laboratory mouse.

Journal: Cell

Published: June 27, 2025

Novel GABAAR antagonists target networked gene hubs at the leading edge in high-grade gliomas.

Journal: Neuro-oncology

Published: June 11, 2025

Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironment.

Journal: BMC cancer

Published: May 07, 2025

Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: January 04, 2024

A pairwise cytokine code explains the organism-wide response to sepsis.

Journal: Nature immunology

Published: April 20, 2023

Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation.

Journal: bioRxiv : the preprint server for biology

Published: February 13, 2023

Enrichment patterns of intrinsic disorder in proteins.

Journal: Biophysical reviews

Published: September 01, 2022

Retrotransposons in Werner syndrome-derived macrophages trigger type I interferon-dependent inflammation in an atherosclerosis model.

Journal: Nature communications

Published: May 07, 2022

B cell-intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice.

Journal: The Journal of experimental medicine

Published: June 24, 2021

Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer.

Journal: Nature communications

Published: March 16, 2021